Aryloxypropanolamine and catecholamine ligand interactions with the β1-adrenergic receptor: Evidence for interaction with distinct conformations of β1-adrenergic receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 923-932

  Konkar, A A ^a   Zhu, Z ^a   Granneman, J G ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADENYLATE CYCLASE; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; CYCLOHEXYL[4 [2 [2 HYDROXY 3 (4 HYDROXYPHENOXY)PROPYLAMINO]ETHYL]PHENOXYMETHYL]PHOSPHINIC ACID; DOBUTAMINE; ISOPRENALINE; LY 362884; NORADRENALIN; PROPANOLAMINE DERIVATIVE; SB 251023; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC STIMULATION; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ADENYLATE CYCLASE; ADRENERGIC ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; BENZIMIDAZOLES; CATECHOLAMINES; CELL LINE; CRICETINAE; HUMANS; LIGANDS; NIACINAMIDE; PROPANOLAMINES; PROTEIN CONFORMATION; RATS; RECEPTORS, ADRENERGIC, BETA-1; TRANSFECTION;

EID: 0033845775     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. 3-adrenoceptor agonist in human right atrial appendage and human white adipocytes
2. 3-adrenoceptor agonists in the treatment of obesity and diabetes
3. Intrinsic activity: Partial agonists and partial antagonists
4. Some quantitative uses of drug antagonists
5. 3-adrenergic receptor
6. 3-adrenergic receptor
7. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat
8. 3 adrenergic receptors to brown fat adenylyl cyclase
9. 4-adrenoceptor
10. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis
11. 3-adrenergic receptor
12. 3-adrenergic receptor gene
13. 3-adrenergic receptors: Involvement of the seventh transmembrane region in conferring subtype specificity
14. CGP 12177A modulates brown fat adenylate cyclase activity by interacting with two distinct receptor sites
15. 2-adrenergic receptor
16. 3-adrenergic receptor agonist for the treatment of obesity and NIDDM
17. Modulation of human cardiac function through 4 β-adrenoceptor populations
18. 3-adrenoceptor knockout mice
19. The Schild regression in the process of receptor classification
20. II. Definition of pharmacological receptors
21. On the importance of the 'antagonist assumption' to how receptors express themselves
22. 3-adrenergic-independent effects of CGP 12177 in brown adipose tissue
23. 3-adrenoceptors in the pithed rat
24. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
25. 3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue
26. 4-adrenoceptor' in mammalian heart
27. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3
28. 1-adrenergic receptors
29. 3-adrenoceptor knockout mice: Evidence for a new β-adrenergic receptor in brown adipose tissue
30. 1-adrenergic receptor gene: Developmental and cardiovascular effects
31. Adenylate cyclase assay
32. 2-adrenergic receptor
33. 4-adrenoceptor' in rat atrium
34. 3H]-CGP 12177 binding
35. 2-adrenergic receptor/G(S) interactions: Evidence for multiple receptor conformations
36. 3-adrenoceptor agonists of differing selectivities
37. CGP-12177 a hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells
38. Rapid and reversible disappearance of β-adrenergic cell surface receptors
39. Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the β1-adrenergic receptor
40. Is the R and R dichotomy real? Observations of allosteric phenomena on G protein-coupled receptors point to problems in the interpretation of agonist-receptor-G protein interactions
41. 2-adrenergic receptor